AbbVie signs $2.9bn deal with I-Mab for ‘don’t eat me’ cancer drugAbbVie has claimed rights to an immuno-oncology antibody from I-Mab in what is thought to be a record Share XAbbVie signs $2.9bn deal with I-Mab for ‘don’t eat me’ cancer drughttps://pharmaphorum.com/news/abbvie-signs-2-9bn-deal-with-i-mab-for-dont-eat-me-cancer-drug/
